Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231

American Journal of Psychiatry

Volumn 160, Issue 2, 2003, Pages 376-379

  Buerger, Katharina ^a   Zinkowski, Raymond ^a   Teipel, Stefan J ^a   Arai, Hiroyuki ^a   DeBernardis, John ^a   Kerkman, Daniel ^a   McCulloch, Cheryl ^a   Padberg, Frank ^a   Faltraco, Frank ^a   Goernitz, Alexander ^a   Tapiola, Tero ^a   Rapoport, Stanley I ^a   Pirttilä, Tuula ^a   Möller, Hans Jürgen ^a   Hampel, Harald ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TAU PROTEIN; THREONINE;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GERIATRIC DEPRESSION SCALE; GERIATRIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; AGED; COMPARATIVE STUDY; DEPRESSION; FEMALE; GERIATRIC ASSESSMENT; MALE; METABOLISM; PHOSPHORYLATION;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; PHOSPHORYLATION; TAU PROTEINS; THREONINE;

EID: 0037315940     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.2.376     Document Type: Article

References (11)

1. Christensen H, Griffiths K, Mackinnon A, Jacomb P: A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. J Int Neuropsychol Soc 1997; 3:631-651
2. Starkstein SE, Petracca G, Chemerinski E, Kremer J: Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 2001; 158:872-877
3. Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro M, Rapoport SI, Möller HJ, Davies P, Hampel H: Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol 2002; 59:1267-1272
4. Buerger K, Teipel SJ, Zinkowski R, Blennow K, Arai H, Engel R, Hofmann-Kiefer K, McCulloch C, Ptok U, Heun R, Andreasen N, DeBernardis J, Kerkman D, Möller HJ, Davies P, Hampel H: CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology 2002; 59:627-629
5. Hampel H, Buerger K, Kohnken R, Teipel SJ, Zinkowski R, Rapoport SI, Möller HJ, Davies P: Tracking of Alzheimer's disease with cerebrospinal fluid tau protein phosphorylated at threonine 231. Ann Neurol 2001; 49:545-546
6. Vincent I, Zheng JH, Dickson DW, Kress Y, Davies P: Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol Aging 1998; 19:287-296
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
8. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
9. Metz CE: Basic principles of ROC analysis. Semin Nucl Med 1978; 8:283-298
10. Jorm AF, Korten AE, Henderson AS: The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987; 76:465-479
11. Jorm AF, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Kokmen E, Kondo K, Mortimer JA, Rocca WA (EURODEM Risk Factors Research Group): Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991; 20(suppl 2):S43-S47